Qualify for a free subscription to HealthLeaders magazine.
This article appears in the April 2014 issue of HealthLeaders magazine.
For years, the hospital autopsy has been dying.
In fact, experts say most hospital policies regard the autopsy as already dead—at best a calcified relic—since the mid-1970s, when The Joint Commission lifted its requirement that hospitals perform autopsies on 20% of inpatient deaths to gain accreditation. Even teaching hospitals have reduced the number they do for training medical students.
Rare is the hospital where the autopsy rate is greater than 5% of nonforensic deaths. At most it's usually only 1%, several pathology experts say.
A big deterrent is the autopsy's cost, $1,000–$3,500 or more, which the hospital usually has to absorb as part of its quality assurance requirements. Medicare embeds this in the episode payment for its beneficiaries without a line item, per se, which means that hospitals can't bill separately for the procedure, although every beneficiary has the right to one if requested.
Revealing information on misdiagnosis
But against all this, a few hospital leaders are resisting the trend, trying to keep the autopsy alive, and even revive it as they campaign for their doctors and families to allow much wider usage. The autopsy can answer questions about contributing causes of death and thus improve quality of care, they say.
"We thought you had x but you ended up dying of y, and that means somewhere between 60,000–80,000 people a year die in the intensive care unit because of misdiagnosis," says Peter J. Pronovost, MD, senior vice president for patient safety and quality at 1,059-bed Johns Hopkins Hospital in Baltimore, Md. Pronovost also is director of the Armstrong Institute for Patient Safety and Quality, also in Baltimore.
A staunch autopsy advocate whose research discovered those statistics, Pronovost says missed infections and unrecognized vascular complications are the most common diagnostic errors resulting in death, and yet many of these complications are preventable.
Recognizing such risks can prompt ultrasound testing to find deep vein thrombosis, which puts patients at risk of potentially lethal pulmonary embolism, he says. The autopsy "is a valuable tool to help us learn how to prevent misdiagnoses in the future," Pronovost says.
Hospitals with good autopsy track records might consider showcasing that as evidence that they are committed to transparency and aren't afraid to learn from their mistakes.
The caveat, however, is that the autopsy must be part of a feedback loop that gets that diagnostic information back to the clinical team, he says. "Where we go wrong, and where people question the autopsy's value, is if the result just sits in pathology and doesn't get back to the team to show ways to improve."
- EHR Systems 'Immature, Costly,' AMA Says
- Better HCAHPS Scores Protect Revenue
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Interstate Medical Licensure Effort Advances
- Narrow Networks Cut Costs, Not Quality, Economists Say
- CEO Exchange: Preparing for Population Health
- Data Points to Boom in Private HIX
- How to Build a Health Plan from Scratch
- 'Early Offer' Malpractice Programs May Spur Reform
- Insurers see cost hikes in Partners HealthCare (MA) mergers